From ex vivo to in vivo chimeric antigen T cells manufacturing: new horizons for CAR T-cell based therapy by E. Pinto, L. Lione, M. Compagnone, M. Paccagnella, E. Salvatori, M. Greco, V. Frezza, E. Marra, L. Aurisicchio, G. Roscilli, A. Conforti

Subjects: “…CAR T cell…”
Get full text

Several factors that predict the outcome of large B‐cell lymphoma patients who relapse/progress after chimeric antigen receptor (CAR) T‐cell therapy can be identified before cell a... by Alice Sýkorová, František Folber, Kamila Polgárová, Heidi Móciková, Juraj Ďuraš, Kateřina Steinerová, Aleš Obr, Adriana Heindorfer, Miriam Ladická, Ľubica Lukáčová, Erika Čellárová, Ivana Plameňová, David Belada, Andrea Janíková, Marek Trněný, Tereza Jančárková, Vít Procházka, Andrej Vranovský, Margaréta Králiková, Jan Vydra, Lukáš Smolej, Ľuboš Drgoňa, Martin Sedmina, Eva Čermáková, Robert Pytlík

Subjects: “…CAR T‐cell failure…”
Get full text

Evaluation of Toxicity Associated with CAR-T Cell Therapy and Nursing Interventions by Seçkin ERDAL, Ayşem KÜNİ, Sevinç SELÇUK, Gülbeyaz CAN

Subjects: “…car-t cell therapy…”
Get full text

Capivasertib enhances chimeric antigen receptor T cell activity in preclinical models of B cell lymphoma by Hui-Ju Hsieh, Ryan Urak, Mary C. Clark, Larry W. Kwak, Stephen J. Forman, Xiuli Wang

Subjects: Get full text

Choice of activation protocol impacts the yield and quality of CAR T cell product, particularly with older individuals by Palak H Mehta, Gemma S Trollope, Patrick Leung, Shivali Savita Chinni, Anna Iasinskaia, Aaron J Harrison, Hannah Hughes‐Parry, Misty R Jenkins, Michael H Kershaw, Anthony Jaworowski, Clare Y Slaney, Rachel M Koldej, David S Ritchie, Kylie M Quinn

Subjects: Get full text

Advances in CAR T cell therapy: antigen selection, modifications, and current trials for solid tumors by Safwaan H. Khan, Safwaan H. Khan, Yeonjoo Choi, Mysore Veena, Mysore Veena, John K. Lee, John K. Lee, Daniel Sanghoon Shin, Daniel Sanghoon Shin

Subjects: “…CAR T cell…”
Get full text

Advancing Multiple Myeloma Immunotherapy: A Review of Chimeric Antigen Receptor T-Cell and Bispecific T-Cell Engagers Cell Therapies in Revolutionizing Treatment by Rahul Navab, Pragyat Futela, Verkha Kumari, Jayesh Valecha, Ramansh Bandhu Gupta, Rohit Jain

Subjects: Get full text

Advancing Chimeric Antigen Receptor T-Cell Therapy for Acute Myeloid Leukemia: Current Limitations and Emerging Strategies by Daniela Damiani, Mario Tiribelli

Subjects: “…CAR T-cell therapy…”
Get full text

Advances in engineered T cell immunotherapy for autoimmune and other non-oncological diseases by Qiaolin Huang, Xiaojian Zhu, Yicheng Zhang

Subjects: Get full text

TITAN Project: Microfluidic and Sensing Tools for Immunotherapy by Maria Serena Chiriacò, Elisabetta Primiceri, Antonio Turco, Valeria Garzarelli, Giulia Siciliano, Alessia Foscarini, Ahmed Alsadig, Annunziata Carbonara, Benedetta Stampone, Gianluca Trotta, Marco Cereda, Marco de Tullio, Giuseppe Gigli, Francesco Ferrara

Subjects: “…CAR-T cell immunotherapy…”
Get full text

Current Advances and Future Prospects in Cancer Immunotherapeutics by Zeynep DEDE, Kader TUMER, Tugce KAN, Burcu YUCEL

Subjects: Get full text

Toll-like receptor 4 signaling activation domains promote CAR T cell function against solid tumors by Veronika Mikolič, Jelica Pantović-Žalig, Špela Malenšek, Matjaž Sever, Duško Lainšček, Roman Jerala

Subjects: “…CAR T cell therapy…”
Get full text

Herpesvirus Infections After Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibodies: A Review by Joseph Sassine, Emily A. Siegrist, Roy F. Chemaly

Subjects: Get full text

Late onset pancytopenia post chimeric antigen receptor T cell therapy triggered by a COVID-19 vaccination: a case report by Nicola Maciocia, Nicola Maciocia, Dean Spencer, Paul Maciocia, Paul Maciocia, Anna Childerhouse, Maeve O’Reilly, Elspeth Payne, Elspeth Payne, Claire Roddie, Claire Roddie

Subjects: Get full text

Outcomes of Idecabtagene Vicleucel Therapy in Patients with Relapsed/Refractory Multiple Myeloma: A Single-Institution Experience by Aaron Trando, Farid Ghamsari, Philip Yeung, Caitlin Costello, Ila Saunders, Ah-Reum Jeong

Subjects: “…CAR T-cell therapy…”
Get full text

Emerging technology trends in regulatory approvals of cancer immunotherapy drugs by the FDA and EMA by Maryam Monajati, Alimohammad Tamaddon, Samira Sadat Abolmaali

Subjects: Get full text

Radiotherapy as a means to increase the efficacy of T-cell therapy in solid tumors by Pierre-Antoine Laurent, Daphne Morel, Lydia Meziani, Stephane Depil, Eric Deutsch

Subjects: Get full text

EEG features and synek scale indicate severity of neurotoxicity in adult patients treated with CD19 CAR T-cell therapy by David Mao, Anne S. Reiner, Xi Chen, Jae Park, Martina Pennisi, Miguel-Angel Perales, Edward K. Avila, Bianca D. Santomasso

Subjects: Get full text

Peptide-guided adaptor-CAR T-Cell therapy for the treatment of SSTR2-expressing neuroendocrine tumors by Christian Pellegrino, Nicholas Favalli, Laura Volta, Ramon Benz, Sara Puglioli, Gabriele Bassi, Kathrin Zitzmann, Christoph Josef Auernhammer, Svenja Nölting, Chiara F. Magnani, Dario Neri, Felix Beuschlein, Markus G. Manz

Subjects: “…Adaptor-CAR T-cell…”
Get full text

Pseudoprogression in CAR-T cell therapy for solid tumor: Case report by Xuan Zhao, Xuan Zhao, Yanfen Liu, Yanfen Liu, Guohui Qin, Guohui Qin, Yan Ge, Qinglong Li, Xinfeng Chen, Xinfeng Chen, Ximei Tian, Yong Yu, Jiangtao Ren, Yi Zhang, Yi Zhang, Yi Zhang, Yi Zhang, Yi Zhang

Subjects: Get full text